Duke University Medical Center
Durham, North Carolina, 27705, United States
NCT Number: NCT00136383
This double-blind placebo-controlled trial is designed to test and to compare the cardiovascular profile of paroxetine controlled release (CR) with duloxetine in outpatients with depressive symptoms.
Looking for future studies?
Notify Me20 year–60 year
All sexes
Interventional
Phase 2 / Phase 3
Durham, North Carolina, 27705, United States
This double-blind placebo-controlled study will test the hypothesis that greater reduction in heart rate variability will be associated with duloxetine than paroxetine in outpatients with major depressive disorder. We will also examine the relationship between changes in heart rate variability to the magnitude of serotonin and norepinephrine transporter occupancy produced by each drug.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Duke University
Other
A Study of the Effects of Paroxetine vs. Duloxetine on Heart Rate Variability and Autonomic Cardiovascular Control
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05925816
Behavior, Behavioral Symptoms
Annandale-on-Hudson, New York, United States
View Trial DetailsNCT04837573
Behavior, Behavioral Symptoms
Los Angeles, California, United States
View Trial DetailsNCT05619510
Behavior, Behavioral Symptoms
Baltimore, Maryland, United States
View Trial DetailsNCT06147297
Anxiety, Anxiety Disorders
Hong Kong
View Trial Details